Timing. Relevance. Relationships.
Fundz is the only platform that reads more than a dozen real‑time signals all day, every day, so you know about new funding, new executives and new contracts within minutes of them happening, not days or weeks later like the databases you’re used to. It then combines the signals on each company, scores every company against what you offer, and weaves in your own network, so you discover new accounts first and work existing ones better.
Each morning you get the ones worth your time right now: who to reach, why now, and who you already know there. Now it answers in Claude too: ask for today’s leads, then write the note in the same window.
Trusted by
Acquiring Company
Oxurion
Acquired Company
Eclevar
Boston
FranceSoftwareConsumer GoodsBiotechnologyHealth CareMedicalDescription
Oxurion has entered into exclusive negotiations to acquire Eclevar, a French CRO specializing in medical devices. The transaction is based on a pricing mechanism linked to Eclevar's future profitability and is targeted for completion by the end of 2026. This acquisition aims to enhance Oxurion's capabilities in the MedTech sector.
Fundz sees it the moment Oxurion makes an acquisition, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Frequently asked
Who acquired Eclevar?
Eclevar was acquired by Oxurion, based in Boston. The deal was reported on September 30, 2026. Oxurion is privately held and operates in Software.
When did Oxurion acquire Eclevar?
Oxurion's acquisition of Eclevar was reported on September 30, 2026. Oxurion has entered into exclusive negotiations to acquire Eclevar, a French CRO specializing in medical devices. The transaction is based on a pricing mechanism linked to Eclevar's future profitability and is targeted for completion by the end of 2026. Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.
What does Eclevar do?
Eclevar is a French clinical research organization (CRO) specializing in the medical devices industry. Over the past years, it has developed a significant customer base across Europe, Japan, and China. It is privately held, operating in Biotechnology, and is based in France.
This company was part of an acquisition. Fundz tracks who bought whom, and who to call on both sides.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.